Overview

Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias

Status:
NOT_YET_RECRUITING

Trial end date:
2026-07-30

Target enrollment:

Participant gender:

Summary

The primary objective is to compare physician-assessed clearance of telangiectatic veins between treatment legs using the Physician Global Aesthetic Improvement Scale (PGAIS). Secondary objectives include assessment of procedural pain, safety outcomes, and patient satisfaction.

Phase:

PHASE4

Details

Lead Sponsor:

Goldman, Butterwick, Fitzpatrick and Groff

Treatments:

Epinephrine
Lidocaine